Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of NH600001 emulsion injection for sedation/anesthesia during gastroscopy
ChiCTR2300069841Phase 2Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Mar 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of NH600001 in None (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Gastroscopy success rate. Started Mar 2023; status: completed.
02
Drugs
NH600001
Beyond the preview
Go deeper on ChiCTR2300069841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069841.